| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26.8B | $7.2B | $46.8B | $56.4B | $52.1B | $43.7B | $11.8B | $12.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $5.1B | $5.5B | $8.5B | $9.2B | $8.8B | $8.4B | $8.5B | $9.3B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $3.1B | $0.9B | $3.6B | $10.3B | $9.4B | $-5.9B | $0.9B | $-0.6B |
| EPS (Basic) | $5.48 | $-2.19 | $5.02 | $13.16 | $10.95 | $-6.88 | $3.79 | $-0.01 |
| EPS (Diluted) | $5.43 | $-2.17 | $4.98 | $13.01 | $10.82 | $-6.88 | $3.74 | $-0.01 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $161.3B | $161.3B | $539.3B | $526.6B | $596.1B | $586.5B | $525.1B | $492.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.3B | $1.3B | $2.2B | $2.0B | $2.2B | $2.8B | $2.9B | $2.9B |
| Total Liabilities | $120.1B | $118.8B | $488.0B | $484.4B | $527.2B | $519.3B | $457.6B | $434.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $41.1B | $42.5B | $45.4B | $40.0B | $66.0B | $66.4B | $65.7B | $56.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.3B | $3.3B | $6.2B | $4.2B | $6.3B | $1.0B | $-0.9B | $0.1B |
| Investing Cash Flow | $3.2B | $1.7B | $-7.0B | $-3.6B | $-3.3B | $-6.2B | $-5.5B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-6.5B | $-5.1B | $0.8B | $-0.7B | $-3.7B | $5.1B | $6.4B | $0.8B |